Market Pathways Scorecard: EUDAMED Snapshot
An infographic look at what has been entered in the EU's EUDAMED database so far as the May 28 date for mandatory registration of certificates, devices, companies, and more approaches.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
An infographic look at what has been entered in the EU's EUDAMED database so far as the May 28 date for mandatory registration of certificates, devices, companies, and more approaches.
With a mission of making cancer care more tolerable to patients, Luminate has advanced device products for the prevention of chemotherapy-induced hair loss and peripheral neuropathy. It’s now overhauling the provision of care itself, with a technology-enabled solution for the delivery of oncology therapeutics at home.
MDUFA VI talks between FDA and industry advance, with some snags. Excerpted from Pathways’ Picks Febraury 11: User Fee Sticking Points, AdvaMed Hire, China Clinical Trial Policy.